G. FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)

12 Months Ended

Dec. 31, 2015

Fair Value Disclosures [Abstract]

Schedule of assets and liabilities at fair value

The following table presents a summary of the Company’s financial instruments measured at fair value on a recurring basis as of December 31, 2015 (in thousands):

	Quoted prices in active markets for identical assets (Level 1)		Significant other observable remaining inputs (Level 2)		Significant unobservable inputs (Level 3)		Total
Assets:
Cash and cash equivalents	$	28,074	$	–	$	–	$	28,074
Restricted cash		4,719		–		–		4,719
Short term investments		7,886		–		–		7,886
Total assets	$	40,679	$	–	$	–	$	40,679
Liabilities:
Bank acceptance payable		–	$	2,998		–	$	2,998
Total liabilities	$	–	$	2,998	$	–	$	2,998

The following table presents a summary of the Company’s financial instruments measured at fair value on a recurring basis as of December 31, 2014 (in thousands):

	Quoted prices in active markets for identical assets (Level 1)		Significant other observable remaining inputs (Level 2)		Significant unobservable inputs (Level 3)		Total
Assets:
Cash and cash equivalents	$	32,175	$	–	$	–	$	32,175
Restricted cash		509		–		–		509
Short term investments		8,189		980		–		9,169
Total assets	$	40,873	$	980	$	–	$	41,853
Liabilities:
Bank acceptance payable		–	$	1,271		–	$	1,271
Total liabilities	$	–	$	1,271	$	–	$	1,271